Here’s what you should know.
1. Analysts believe the market will grow at a compound annual growth rate of 2.3 percent.
2. The fully mature market has not experienced any innovation over the last decade, according to the report.
3. Revenue growth is dwindling in the market as device prices continue to drop.
4. Market analyst Tobe Madu said the market has multiple possible paths it could grow in over the next six years. He said robotic technology investments would lower the revision surgery caseload, but increase initial cost. However if the market explores generic implants, director cost of surgery would decrease, but revision rates could possibly increase.
5. Analysts expect knee replacements rates to continuing growing because of an aging patient base.
More articles on orthopedics:
After 2nd ACL reconstruction, significant number of patients need subsequent procedures
Virginia Tech University names Dr. Mark Rogers athletics health care administrator — 3 key notes
Oklahoma State University opening new sports medicine clinic — 3 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.